These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30719836)

  • 1. Canine oral primary melanoma cells exhibit shift to mesenchymal phenotype and phagocytic behaviour.
    Schmid F; Brodesser D; Reifinger M; Forte S; Semp P; Eberspächer-Schweda MC; Wolschek M; Brandt S; Kleiter M; Pratscher B
    Vet Comp Oncol; 2019 Sep; 17(3):211-220. PubMed ID: 30719836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
    Docampo MJ; Cabrera J; Rabanal RM; Bassols A
    Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression and prognostic significance of MAGE-A in canine oral malignant melanoma.
    Guillén A; Stiborova K; Ressel L; Blackwood L; Finotello R; Amores-Fuster I; Jama N; Killick D
    Res Vet Sci; 2021 Jul; 137():226-234. PubMed ID: 34023546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma.
    Koenig A; Wojcieszyn J; Weeks BR; Modiano JF
    Vet Pathol; 2001 Jul; 38(4):427-35. PubMed ID: 11467477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical Expression of MCAM/CD146 in Canine Melanoma.
    Abou Asa S
    J Comp Pathol; 2017 Jul; 157(1):27-33. PubMed ID: 28735667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions.
    Qiao B; Johnson NW; Gao J
    Int J Oncol; 2010 Sep; 37(3):663-8. PubMed ID: 20664935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and activity levels of matrix metalloproteinase 2 and 9 in canine and feline osteosarcoma.
    Gebhard C; Fuchs-Baumgartinger A; Razzazi-Fazeli E; Miller I; Walter I
    Can J Vet Res; 2016 Jan; 80(1):66-73. PubMed ID: 26733734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
    Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
    Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of Canine Oral Mucosal Melanoma Cell Lines and Their Xenogeneic Animal Models.
    Li S; Liu Z; Lv J; Lv D; Xu H; Shi H; Liu G; Lin D; Jin Y
    Cells; 2024 Jun; 13(11):. PubMed ID: 38891124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Delta-like 3 restricts lipopolysaccharide-induced inflammation, migration and invasion of A2058 melanoma cells via blocking Twist1-mediated epithelial-mesenchymal transition.
    Ding X; Li F; Zhang L
    Life Sci; 2019 Jun; 226():149-155. PubMed ID: 30981764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of matrix metalloproteinase-2 (MMP-2) in canine oronasal tumors.
    Nakaichi M; Yunuki T; Okuda M; Une S; Taura Y
    Res Vet Sci; 2007 Apr; 82(2):271-9. PubMed ID: 17011604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical assessment of metalloproteinases MMP2 and MMP9 expression in canine various subtypes of lymphomas in relation with proliferative and apoptotic markers.
    Sokołowska J; Urbańska K
    Pol J Vet Sci; 2019 Jun; 22(2):203-211. PubMed ID: 31269334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous knockdown of uPA and MMP9 can reduce breast cancer progression by increasing cell-cell adhesion and modulating EMT genes.
    Moirangthem A; Bondhopadhyay B; Mukherjee M; Bandyopadhyay A; Mukherjee N; Konar K; Bhattacharya S; Basu A
    Sci Rep; 2016 Feb; 6():21903. PubMed ID: 26906973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma.
    Mayayo SL; Prestigio S; Maniscalco L; Rosa G; Aricò A; Maria R; Cavallo F; Ferrone S; Buracco P; Iussich S
    Vet J; 2011 Nov; 190(2):e26-e30. PubMed ID: 21482159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas.
    Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Uchida K; Kadosawa T; Taniyama H
    Vet Pathol; 2017 Sep; 54(5):783-791. PubMed ID: 28494700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of STC2 gene silencing on colorectal cancer cells.
    Li Q; Zhou X; Fang Z; Pan Z
    Mol Med Rep; 2019 Aug; 20(2):977-984. PubMed ID: 31173256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interplay of MicroRNA-34a, LGR4, EMT-Associated Factors, and MMP2 in Regulating Uveal Melanoma Cells.
    Hou Q; Han S; Yang L; Chen S; Chen J; Ma N; Wang C; Tang J; Chen X; Chen F; Dong XDE; Tu L
    Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4503-4510. PubMed ID: 31661551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits.
    Tester AM; Ruangpanit N; Anderson RL; Thompson EW
    Clin Exp Metastasis; 2000; 18(7):553-60. PubMed ID: 11688960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of RHOC by shRNA suppresses invasion and migration of cholangiocellular carcinoma cells via inhibition of MMP2, MMP3, MMP9 and epithelial-mesenchymal transition.
    Yang H; Liang J; Zhou J; Mi J; Ma K; Fan Y; Ning J; Wang C; Wei X; Li E
    Mol Med Rep; 2016 Jun; 13(6):5255-61. PubMed ID: 27108649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.